IPO registrations (S-1, F-1) · Registrants
BioRestorative Therapies, Inc.
- SEC CIK
- 1505497 · filings on EDGAR ↗
- Former names
- Stem Cell Assurance, Inc. (2010–2011)
- Registration
- Form S-1, first filed 2015-06-03, last 2026-02-10; 7 initial registrations, 10 amendments
- Outcome
- Final prospectus filed 2015-12-02; declared effective 2015-11-09; withdrawal requested 2018-09-21
- Industry (SIC)
- Services-Misc Health & Allied Services, NEC 8090
- Incorporated in
- NV
- Business address
- 40 MARCUS DRIVE, SUITE ONE, Melville, NY
- EIN
- 30-1341024
- Ticker
- BRTX (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- BioRestorative Therapies, Inc. on the corporate pages
Offering terms
- Final price
- $5.25 per share (424B4 filed 2015-12-02)
- Shares sold
- 952,380
- Gross proceeds
- $4,999,995 before underwriting discounts and any over-allotment option
- Listing
- OTCQB under the symbol BRTX
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: BIORESTORATIVE THERAPIES INC Fuzzy (name and state)
- Business registration: BIORESTORATIVE THERAPIES, INC. Fuzzy (name and state)
- Business registration: BIORESTORATIVE THERAPIES, INC. Fuzzy (name and state)
- Federal award recipient: BIORESTORATIVE THERAPIES, INC. Fuzzy (name and state)
- Form D issuer: BioRestorative Therapies, Inc. EXACT (CIK (EXACT))
- SEC filer: BioRestorative Therapies, Inc. EXACT (CIK (EXACT))
Filings 32
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-06-03 | S-1 | S-1 (registration) | BioRestorative Therapies, Inc. | 0001144204-15-035236 ↗ |
| 2015-09-25 | S-1/A | S-1/A (amendment) | BioRestorative Therapies, Inc. | 0001144204-15-056582 ↗ |
| 2015-10-16 | S-1/A | S-1/A (amendment) | BioRestorative Therapies, Inc. | 0001144204-15-059826 ↗ |
| 2015-10-27 | S-1/A | S-1/A (amendment) | BioRestorative Therapies, Inc. | 0001144204-15-060840 ↗ |
| 2015-11-05 | S-1/A | S-1/A (amendment) | BioRestorative Therapies, Inc. | 0001144204-15-063158 ↗ |
| 2015-11-09 | EFFECT | EFFECT (declared effective) | BioRestorative Therapies, Inc. | 9999999995-15-003001 ↗ |
| 2015-12-02 | 424B4 | 424B4 (final prospectus) | BioRestorative Therapies, Inc. | 0001144204-15-069006 ↗ |
| 2017-10-05 | S-1 | S-1 (registration) | BioRestorative Therapies, Inc. | 0001493152-17-011351 ↗ |
| 2018-09-21 | RW | RW (withdrawal request) | BioRestorative Therapies, Inc. | 0001021771-18-000058 ↗ |
| 2019-04-26 | S-1 | S-1 (registration) | BioRestorative Therapies, Inc. | 0001493152-19-006013 ↗ |
| 2019-09-06 | S-1/A | S-1/A (amendment) | BioRestorative Therapies, Inc. | 0001493152-19-013825 ↗ |
| 2021-08-06 | S-1 | S-1 (registration) | BioRestorative Therapies, Inc. | 0001493152-21-018939 ↗ |
| 2021-10-18 | S-1/A | S-1/A (amendment) | BioRestorative Therapies, Inc. | 0001493152-21-025629 ↗ |
| 2021-10-29 | S-1/A | S-1/A (amendment) | BioRestorative Therapies, Inc. | 0001493152-21-026766 ↗ |
| 2021-11-04 | S-1/A | S-1/A (amendment) | BioRestorative Therapies, Inc. | 0001493152-21-027195 ↗ |
| 2021-11-04 | S-1MEF | S-1MEF (added securities) | BioRestorative Therapies, Inc. | 0001493152-21-027276 ↗ |
| 2021-11-04 | EFFECT | EFFECT (declared effective) | BioRestorative Therapies, Inc. | 9999999995-21-004196 ↗ |
| 2021-11-09 | 424B4 | 424B4 (final prospectus) | BioRestorative Therapies, Inc. | 0001493152-21-027544 ↗ |
| 2021-11-23 | RW | RW (withdrawal request) | BioRestorative Therapies, Inc. | 0001021771-21-000097 ↗ |
| 2022-06-16 | EFFECT | EFFECT (declared effective) | BioRestorative Therapies, Inc. | 9999999995-22-001804 ↗ |
| 2022-10-04 | EFFECT | EFFECT (declared effective) | BioRestorative Therapies, Inc. | 9999999995-22-002911 ↗ |
| 2023-02-14 | EFFECT | EFFECT (declared effective) | BioRestorative Therapies, Inc. | 9999999995-23-000435 ↗ |
| 2024-04-03 | S-1 | S-1 (registration) | BioRestorative Therapies, Inc. | 0001021771-24-000084 ↗ |
| 2024-04-12 | S-1/A | S-1/A (amendment) | BioRestorative Therapies, Inc. | 0001021771-24-000099 ↗ |
| 2024-04-18 | EFFECT | EFFECT (declared effective) | BioRestorative Therapies, Inc. | 9999999995-24-001030 ↗ |
| 2025-11-18 | S-1 | S-1 (registration) | BioRestorative Therapies, Inc. | 0001493152-25-024081 ↗ |
| 2025-12-10 | EFFECT | EFFECT (declared effective) | BioRestorative Therapies, Inc. | 9999999995-25-003635 ↗ |
| 2026-02-09 | S-1 | S-1 (registration) | BioRestorative Therapies, Inc. | 0001493152-26-005827 ↗ |
| 2026-02-10 | S-1/A | S-1/A (amendment) | BioRestorative Therapies, Inc. | 0001493152-26-006012 ↗ |
| 2026-02-11 | EFFECT | EFFECT (declared effective) | BioRestorative Therapies, Inc. | 9999999995-26-000543 ↗ |
| 2026-02-13 | 424B4 | 424B4 (final prospectus) | BioRestorative Therapies, Inc. | 0001493152-26-006580 ↗ |
| 2026-04-28 | EFFECT | EFFECT (declared effective) | BioRestorative Therapies, Inc. | 9999999995-26-001353 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-11-05 | S-1/A | registration statement | 842,106 | - | OTCQB BRTX | 0 | primary document; shares headline | document ↗ | ||
| 2015-12-02 | 424B4 | final prospectus | $5.25 | 952,380 | $4,999,995 | OTCQB BRTX | 0 | primary document; price line, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Clark Mandy D. | Officer | VP of Operations | 14 | 2011–2019 | |
| San Antonio Joel | Director | 6 | 2011–2014 | ||
| Weinreb Mark | Director,Officer; Director,Officer,TenPercentOwner | CEO and Chairman of the Board | 16 | 2011–2019 | |
| Silva Francisco | Director,Officer; Director,Officer,TenPercentOwner; Officer | VP of Research and Development | 41 | 2011–2025 | |
| Radov A. Jeffrey | Director | 15 | 2011–2019 | ||
| WESTBURY BERMUDA LTD | TenPercentOwner | 6 | 2013–2015 | ||
| Westbury Trust | TenPercentOwner | 6 | 2013–2015 | ||
| Swiader Joseph B | Director | 10 | 2014–2015 | ||
| Tonna Paul Jude | Director | 13 | 2014–2019 | ||
| Montgomery Janet | TenPercentOwner | 1 | 2014 | ||
| Montgomery Stuart | TenPercentOwner | 1 | 2014 | ||
| Field Edward L. | Officer | President brtxDISC Division | 6 | 2015–2017 | |
| Ryan Charles S. | Director | 11 | 2015–2019 | ||
| Desmarais John M | Director; Director,TenPercentOwner | 16 | 2015–2019 | ||
| CATELL ROBERT B | Director | 13 | 2016–2019 | ||
| BERGSTEIN ADAM D. | Officer | SVP, Planning and Business Dev | 2 | 2018 | |
| Paccasassi Robert | Officer | VP, QA and Reg Compliance; VP, Quality and Compliance | 6 | 2018–2024 | |
| ALSTODT LANCE | Director,Officer; Director,Officer,TenPercentOwner; Officer | EVP and Chief Strategy Officer; President, CEO, COB | 48 | 2018–2025 | |
| Broadrick Dale | TenPercentOwner | 34 | 2019–2024 | ||
| Kukekov Nickolay V. | Director | 6 | 2021–2025 | ||
| Rosa David A | Director | 6 | 2021–2025 | ||
| Williams Patrick F. | Director | 6 | 2021–2025 | ||
| Kristal Robert Eugene | Officer | Chief Financial Officer | 9 | 2021–2025 | |
| Field Katharyn | Director | 1 | 2026 | ||
| Dhaliwal Jatinder | Director | 1 | 2026 | ||
| Grasso Mika | Director | 1 | 2026 | ||
| Brown Steven Collier | Director | 1 | 2026 | ||
| Randhawa Esha | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-10-09 | BioRestorative Therapies, Inc. | Biotechnology | $1,398,628 | $1,398,628 | 16 | 1 |
| 2014-03-26 | BioRestorative Therapies, Inc. | Biotechnology | $1,183,767 | $585,809 | 21 | 1 |
| 2014-03-20 | BioRestorative Therapies, Inc. | Biotechnology | Indefinite | $14,395,044 | 81 | 4 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | BIORESTORATIVE THERAPIES INC | NY | State business registries | name and state |
| Business registration | BIORESTORATIVE THERAPIES, INC. | NY | State business registries | name and state |
| Business registration | BIORESTORATIVE THERAPIES, INC. | NY | State business registries | name and state |
| Federal award recipient | BIORESTORATIVE THERAPIES, INC. | NY | Federal spending (USAspending) | name and state |
| Form D issuer | BioRestorative Therapies, Inc. | NY | Form D private offerings | CIK (EXACT) |
| Patent assignee | BIORESTORATIVE THERAPIES, INC. | NY | Patents (USPTO) | name and state |
| SEC filer | BioRestorative Therapies, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | BIORESTORATIVE THERAPIES, INC. | NY | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Misc Health & Allied Services, NEC, NY first:
- AHT CORP NY
- Progyny, Inc. NY
- Elements Ventures Group Inc. A6
- STERIGENICS INTERNATIONAL INC CA
- iVOW, Inc. CA
- DRKOOP COM INC CA
- DR. TATTOFF, INC. CA
- BASIC CARE NETWORKS INC CA
- CombiMatrix Corp CA
- IPC Healthcare, Inc. CA
In other datasets, the same topic (Health) in NY:
- Nonprofit: AABR FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Services-Misc Health & Allied Services, NEC · Health